Please note that to be eligible for the test, you must be 50 years or older.
Healthy holidays!
This season, prioritize health for yourself and your loved ones by screening for multiple cancers with the Galleri test. For a limited time, receive $50 off.*
The Galleri test is available by prescription only.
Download the discussion guide
The discussion guide helps you talk to your healthcare provider so they can determine if the test is right for you. The guide also provides instructions for your provider to order the test for you.
Your test must be ordered by a healthcare provider AND blood draw completed by January 31, 2025, to receive $50 off.*
Request the test online
Request the test online through an independent telemedicine provider and select “I have a Galleri Key.” Enter the Galleri Key to receive $50 off*: 24GIFT50
Your test must be ordered by December 31, 2024, to receive $50 off.*
This offer is available through your provider or tests can be requested online at Galleri.com through an independent telemedicine provider. You must be 50 or older to take advantage of the online offer. Eligibility will be assessed at the time of your test request. The discount only applies to full-priced, self-pay tests priced at $949. Most health insurance plans do not cover the Galleri test.
*Limited time offer valid only for Galleri test orders placed November 28, 2024, midnight PST through the applicable Offer End Date (defined below). Valid only for Galleri test orders requested online and approved by the GRAIL-contracted independent telemedicine provider (“Telemedicine Order”) or by your independent healthcare provider using the GRAIL-provided Test Requisition Form specifically for this offer (“Clinic Order”). The “Offer End Date” means: (i) for Telemedicine Orders, December 31, 2024, 11:59 pm PST; (ii) for Clinic Orders, January 31, 2025, 11:59 pm PST. Valid for Clinic Orders only if the blood draw for the Galleri test is completed by the applicable Offer End Date. Offer does not confirm your eligibility for the Galleri test. Valid only for one-time use on domestic US Galleri test orders only. Offer valid only for a discount off the Galleri test list price ($949). Offer cannot be: (1) combined or used with any other discount, promotion, special pricing, or payment plan; (2) used to request a credit on a test order placed prior to the offer period; or (3) posted online or on any other publicly available forum. GRAIL reserves the right to change the terms and conditions, substitute an offer of equal or greater value, and end the offer at any time without notice. For Galleri test orders requested online, you must create an account to redeem this offer and enter the code at the “Introduction” stage, where prompted.
Have a question?
The Galleri test is recommended for use in adults with an elevated risk for cancer, such as those aged 50 or older. The Galleri test does not detect all cancers and should be used in addition to routine cancer screening tests recommended by a healthcare provider. Galleri is intended to detect cancer signals and predict where in the body the cancer signal is located. Use of Galleri is not recommended in individuals who are pregnant, 21 years old or younger, or undergoing active cancer treatment.
Results should be interpreted by a healthcare provider in the context of medical history, clinical signs and symptoms. A test result of No Cancer Signal Detected does not rule out cancer. A test result of Cancer Signal Detected requires confirmatory diagnostic evaluation by medically established procedures (e.g. imaging) to confirm cancer.
If cancer is not confirmed with further testing, it could mean that cancer is not present or testing was insufficient to detect cancer, including due to the cancer being located in a different part of the body. False-positive (a cancer signal detected when cancer is not present) and false-negative (a cancer signal not detected when cancer is present) test results do occur. Rx only.
The GRAIL clinical laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) and accredited by the College of American Pathologists. The Galleri test was developed and its performance characteristics were determined by GRAIL. The Galleri test has not been cleared or approved by the Food and Drug Administration. The GRAIL clinical laboratory is regulated under CLIA to perform high-complexity testing. The Galleri test is intended for clinical purposes.